Register Online | Request agenda


Event Overview
Summary: Why Attend?
Who Should Attend?
Speakers


Risk Sharing World 2010

Event Overview:

Without innovative action, demographic trends indicate that healthcare costs will continue to rise for the foreseeable future; a dire economic situation, sweeping reforms, ballooning discovery and development costs and slow regulatory approval not withstanding. Pharmaceutical companies are compelled to abandon traditional reimbursement models to ensure a sustainable future. There is a need for innovative models, such as risk sharing and value-based pricing agreements, to obtain health technology assessor (HTA) approval necessary for financing drugs from increasingly tight budgets. Gain a clear understanding of what innovative pricing and reimbursement models require, by examining the most up to date case studies and regulatory precedents. Hear the vested interest of all stakeholders, to understand conflicting objectives and how they may be most successfully appeased. Without this critical information executives will lack the tools necessary to reconcile the conflicting incentives of all parties involved and implement their own innovative agreements to secure market access, the world over.



Summary: Why Attend?


 

Who Should Attend?


 

Speakers: